Asian Spectator

Men's Weekly

.

Jemincare Announces the Exclusive License of the Kras Inhibito...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SHANGHAI, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Female genital cutting: why Southeast Asia should follow Africa’s lead in challenging religious and cultural justifications

Illustration of campaign against Female Genital Mutilation (FGM).Tunatura/ShutterstockFemale genital mutilation or cutting (FGM/C) remains a threat to the rights of women in Southeast Asia, often reli...

Manfaat tempe juga bisa menyehatkan tulang: Mengapa pengakuan dari UNESCO saja tidak cukup?

● Sejumlah negara (seperti Belgia dan Jepang) merekomendasikan warganya memperbanyak konsumsi tempe. ● Tempe punya banyak manfaat kesehatan, termasuk bagi kesehatan tulang.● Pemerint...

Pemberdayaan warga jadi solusi efektif meredam abrasi: Pelajaran dari pesisir Bulukumba

● Indonesia memiliki banyak kawasan pesisir rawan abrasi ekstrem, seperti di Bulukumba, Sulawesi Selatan.● Pemberdayaan masyarakat setempat amat krusial untuk mencegah abrasi.● Pemba...